# PROXIMAGEN LLC – FDA Inspection, Mar 5, 2019

Source: https://www.keypedia.com/records/fda_inspections/proximagen-llc/f5f44dbe-801e-4a9f-a6c3-c44872ea4d08
Source feed: FDA_Inspections

> FDA inspection 1081434 of PROXIMAGEN LLC, March 05, 2019. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 820. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1081434
- Company Name: PROXIMAGEN LLC
- Inspection Date: 2019-03-05
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Minneapolis District Office
- Citation Count: 5

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/james-k-ireland/78658286-3e62-4069-a8e1-b157aa77c7fe)
- [Company Rep](https://www.keypedia.com/people/susan-m-matthias/cd23c465-4411-4988-8676-2089e265622a)

Company: https://www.keypedia.com/companies/proximagen-llc/7964c75a-2e7c-4b2f-a219-841c8489efbe

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d